Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RUTI Vaccine in Latent Tuberculosis
NCT01136161Phase 2Completed
- Sponsor
- Archivel Farma
- Start
- Jun 2010
- Primary completion
- May 2011
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
A Phase 2 trial of RUTI vaccine in Tuberculosis (TB), sponsored by Archivel Farma. Started Jun 2010; status: completed.
02
Drugs
RUTI vaccine
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT01136161.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01136161.